Navigation Links
Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
Date:5/8/2009

SHENZHEN, China, May 8 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2008. An electronic version of Mindray's Annual Report on Form 20-F is available online at Mindray's investor relations website at http://ir.mindray.com , or at http://www.sec.gov .

Investors may obtain a printed copy of Mindray's audited financial statements free of charge by contacting Mindray Investor Relations either by phone, e-mail or in writing at the address below:

    ATTN: Investor Relations
    Mindray Building
    Keji 12th Road South, High-tech Industrial Park
    Nanshan, Shenzhen 518057
    P.R. China.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com .

    For investor and media inquiries please contact:

    In the U.S.:

     Evan Smith, CFA
     FD
     Tel:   +1-212-850-5606
   
'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
2. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
3. Mindray Announces Option Exchange Offer
4. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
5. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
6. Mindray Announces Preliminary 2008 Operating Results
7. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
9. Mindray Announces 2008 Third Quarter and Nine Months Results
10. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008
11. Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....24/PRNewswire/--Whiletheholidayseasonoftenbringsf...yearcanbedifficultforthosegrievingthedeathofaloved...andfamilies.Theholidayseasoncanbringadditionalchal...ngPlace,ACenterforGrievingChildren,AdolescentsandT...dditiontohavingavarietyofprintandonlineresourcesav...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--HealthSouthCorpora...heBankofAmericaMerrillLynch2009CreditConferenceinN...residentandTreasurerEdFaywillbespeakingonThursday,...stliveandwillbeavailableat http://investor.healths...HealthSouth ,, HealthSouthisthenation,slargest...
(Date:11/24/2009)...s didn,t differ greatly between high- and low-volu.... 24 (HealthDay News) -- Do hospitals that conduct...st results for patients? Maybe not. , Prior res...when it comes to artery-opening procedures, but a ...- and high-volume hospitals performing more or les...
(Date:11/24/2009)...a,Nov.24/PRNewswire-FirstCall/-HardtoTreatDiseases...gsubsidiarySlavicaBioChem,isprovidingthisbriefupda...inuesduediligencewiththeEUstemcellcompanyandmerger...oraboutOct29,2009whichthecompanymade. http://www.p...News . ,, HTDSandSlavicaBiochemarealsodiscussin...
(Date:11/24/2009)...24/PRNewswire/--Metastorm,aleadingproviderofBusine...PA),andEnterpriseArchitecture(EA)softwareforaligni...merisourceBergenCorporation,oneoftheworld,slargest...rdforNorthAmericainthe2009GlobalAwardsforExcellenc...implementationofMetastorm,sBPMsoftware.Theawardrec...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2
...arch 5 AmericInn(R) International, LLC officially...,s new sleep advocacy and awareness campaign, with.... The new Web portal is designed to educate consum...ter America" Web site centralizes unique sleep-rel...
... 3, 2009) - How messages sent within stem cells th... the cells to specialize and become blood cells in...McMaster Stem Cell and Cancer Research Institute. ...way, known as the noncanonical Wnt, in inducing bl...
...lternative Reproductive Resources (ARR) today ann...economic realities given the investment required f... Alternatives ," it offers incentive pricing to in...ome egg donors," said Robin von Halle, president o...
...cabbage block protein in disease spread, study say...- A drug based on compounds extracted from crucife... offer a potent and safe treatment against melanom...production and blocked the signaling network of a ...
... and Asia to Realize New Executive Leadership , ,...okyo Stock Exchange), a leading medical diagnosti...ion systems developer, today announced executive l... Sysmex Corporate after a six-year tenure in the U...
...clinical trial involving more than 3,000 women in ...first time the promise of a vaginal microbicide ge... to findings presented at the Conference on Retrov...30% effective. While the results are encouraging, ...
Other Medicine News:Health News:AmericInn Hotels Kicks-Off 'Sleep Better America' With Launch of New Web Site to Educate Consumers About Insomnia and Sleep-Related Issues 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Clinical trial finds microbicide promising as HIV prevention method for women 2
(Date:11/24/2009)...swire-FirstCall/--EchoTherapeutics,Inc.(OTCBulleti...ony(TM)tCGMSystemasanon-invasive,wireless,transder...elude(TM)SkinPrepSystemfortransdermaldrugdelivery,...ChiefExecutiveOfficer,willpresentatthe13thAnnualBi...edbytheNewYorkSocietyofSecuritiesAnalysts,at2:05on...
(Date:11/24/2009)...e/--MAQUETCardiovascularLLC,aleadingproviderofcard...edaguaranteedtwo-yearcontractwithNovation,oneofthe...esolesourceproviderofsurgicaldevicesforbeatinghear...,whichrunsthroughOctober31,2012,MAQUETCardiovascul...nddisposablesuppliestothemembersofVHAInc.andUniver...
(Date:11/24/2009)...wswire-FirstCall/--IsisPharmaceuticals,Inc.(Nasdaq...ouncedthatmanagementwillpresentacompanyoverviewatP...ay,December1,2009,at10:30a.m.ETatTheNewYorkPalaceH...beavailableonthe"Investors&Media"sectionoftheC...esentationwillbeavailableontheIsisWebsitewithin48h...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Safe Ozone Levels May Not Be for Some 52829 1Safe Ozone Levels May Not Be for Some 52829 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 1Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 2
...DIEGO, Dec. 5 Orexigen(R) Therapeutics, Inc.,(Nas...the Company,s resources,focus its efforts on its l...ent team. , The key aspects of these changes...-of-concept Phase 2 trials for OREX-003,(zonisamid...ted weight gain),and OREX-004 (fluoxetine and nalt...
...ERDAM, December 4 Biopharmaceutical company Kiadi...completed treatment of the,last patient on its ATI...,lymphocyte cell based product, is under developme...D) and allow early immune reconstitution following...n end stage blood cancer,patients were treated wit...
Other Medicine Technology:Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 2Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 3Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2
Kerrison style punch
Aaron 2250 Electrosurgery Generator
Sabre 2400 Electrosurgery Generator, 240V, 50Hz
ExcaliburPlus PC Electrosurgery Generator, 100V, 50Hz/60Hz
Medicine Products: